TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3

Benzinga Newsdesk www.benzinga.com Negative 81.2%

Neg 81.2% Neu 0% Pos 0%

TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $8 to $3.